These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 25775094)

  • 1. Recent advances in novel heterocyclic scaffolds for the treatment of drug-resistant malaria.
    Kumar S; Singh RK; Patial B; Goyal S; Bhardwaj TR
    J Enzyme Inhib Med Chem; 2016; 31(2):173-86. PubMed ID: 25775094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trioxaferroquines as new hybrid antimalarial drugs.
    Bellot F; Coslédan F; Vendier L; Brocard J; Meunier B; Robert A
    J Med Chem; 2010 May; 53(10):4103-9. PubMed ID: 20443628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimalarial drug development: past to present scenario.
    Dhanawat M; Das N; Nagarwal RC; Shrivastava SK
    Mini Rev Med Chem; 2009 Oct; 9(12):1447-69. PubMed ID: 19929818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimalarials from nature.
    Kaur K; Jain M; Kaur T; Jain R
    Bioorg Med Chem; 2009 May; 17(9):3229-56. PubMed ID: 19299148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A review on diverse heterocyclic compounds as the privileged scaffolds in antimalarial drug discovery.
    Kalaria PN; Karad SC; Raval DK
    Eur J Med Chem; 2018 Oct; 158():917-936. PubMed ID: 30261467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ferroquine and its derivatives: new generation of antimalarial agents.
    Wani WA; Jameel E; Baig U; Mumtazuddin S; Hun LT
    Eur J Med Chem; 2015 Aug; 101():534-51. PubMed ID: 26188909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent Developments in Natural Product Inspired Synthetic 1,2,4- Trioxolanes (Ozonides): An Unusual Entry into Antimalarial Chemotherapy.
    Tiwari MK; Yadav DK; Chaudhary S
    Curr Top Med Chem; 2019; 19(10):831-846. PubMed ID: 30977453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ferrocene-based antimalarials.
    Roux C; Biot C
    Future Med Chem; 2012 Apr; 4(6):783-97. PubMed ID: 22530641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, Synthesis, and Evaluation of Novel Ferroquine and Phenylequine Analogues as Potential Antiplasmodial Agents.
    Jacobs L; de Kock C; de Villiers KA; Smith PJ; Smith VJ; van Otterlo WA; Blackie MA
    ChemMedChem; 2015 Dec; 10(12):2099-110. PubMed ID: 26447782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ferrocene-Based Compounds with Antimalaria/Anticancer Activity.
    Peter S; Aderibigbe BA
    Molecules; 2019 Oct; 24(19):. PubMed ID: 31591298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and antiplasmodial activity of new heteroaryl derivatives of 7-chloro-4-aminoquinoline.
    Casagrande M; Barteselli A; Basilico N; Parapini S; Taramelli D; Sparatore A
    Bioorg Med Chem; 2012 Oct; 20(19):5965-79. PubMed ID: 22917857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel hybrid molecules based on 15-membered azalide as potential antimalarial agents.
    Starčević K; Pešić D; Toplak A; Landek G; Alihodžić S; Herreros E; Ferrer S; Spaventi R; Perić M
    Eur J Med Chem; 2012 Mar; 49():365-78. PubMed ID: 22321992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comprehensive review on synthetic approach for antimalarial agents.
    Kumar A; Paliwal D; Saini D; Thakur A; Aggarwal S; Kaushik D
    Eur J Med Chem; 2014 Oct; 85():147-78. PubMed ID: 25084143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimalarial activity of new acridinone derivatives.
    Fernández-Calienes A; Pellón R; Docampo M; Fascio M; D'Accorso N; Maes L; Mendiola J; Monzote L; Gille L; Rojas L
    Biomed Pharmacother; 2011 Jun; 65(3):210-4. PubMed ID: 21641752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of the antimalarial activity of ciprofloxacin using a double prodrug/bioorganometallic approach.
    Dubar F; Anquetin G; Pradines B; Dive D; Khalife J; Biot C
    J Med Chem; 2009 Dec; 52(24):7954-7. PubMed ID: 19908867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and synthesis of new antimalarial agents from 4-aminoquinoline.
    Solomon VR; Puri SK; Srivastava K; Katti SB
    Bioorg Med Chem; 2005 Mar; 13(6):2157-65. PubMed ID: 15727868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent developments in antimalarial activities of 4-aminoquinoline derivatives.
    Ravindar L; Hasbullah SA; Rakesh KP; Hassan NI
    Eur J Med Chem; 2023 Aug; 256():115458. PubMed ID: 37163950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From hybrid compounds to targeted drug delivery in antimalarial therapy.
    Oliveira R; Miranda D; Magalhães J; Capela R; Perry MJ; O'Neill PM; Moreira R; Lopes F
    Bioorg Med Chem; 2015 Aug; 23(16):5120-30. PubMed ID: 25913864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 4-Aminoquinoline derivatives: Synthesis, in vitro and in vivo antiplasmodial activity against chloroquine-resistant parasites.
    Singh S; Agarwal D; Sharma K; Sharma M; Nielsen MA; Alifrangis M; Singh AK; Gupta RD; Awasthi SK
    Eur J Med Chem; 2016 Oct; 122():394-407. PubMed ID: 27394399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Piperazine-linked 4-aminoquinoline-chalcone/ferrocenyl-chalcone conjugates: Synthesis and antiplasmodial evaluation.
    Singh A; Rani A; Gut J; Rosenthal PJ; Kumar V
    Chem Biol Drug Des; 2017 Oct; 90(4):590-595. PubMed ID: 28332319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.